Assura Plc (ARSSF)

OTCMKTS · Delayed Price · Currency is USD
0.6060
+0.0005 (0.08%)
Apr 23, 2025, 4:00 PM EDT
25.21%
Market Cap 2.08B
Revenue (ttm) 220.35M
Net Income (ttm) 88.59M
Shares Out n/a
EPS (ttm) 0.03
PE Ratio 23.49
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 6,151
Open 0.6055
Previous Close 0.6055
Day's Range 0.6055 - 0.6060
52-Week Range 0.4320 - 0.6400
Beta 0.57
RSI 53.59
Earnings Date May 15, 2025

About Assura

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura, we BUILD for health, having developed over 100 new hea... [Read more]

Sector Real Estate
Founded 2003
Employees 84
Stock Exchange OTCMKTS
Ticker Symbol ARSSF
Full Company Profile

Financial Performance

In 2023, Assura's revenue was 157.80 million, an increase of 4.92% compared to the previous year's 150.40 million. Losses were -28.80 million, -75.84% less than in 2022.

Financial numbers in GBP Financial Statements

News

GP surgeries owner Assura agrees to private equity takeover worth £1.61bn

The London-listed company will be bought by Kohlberg Kravis Roberts (KKR) and Stonepeak Partners.

15 days ago - Evening Standard

UK Stock Market News: SAGA, Assura, PageGroup

SAGA, Assura and PageGroup feature as Tony Cross's three headlines from today's London stock market open

15 days ago - The Armchair Trader

UK Stock Market News: Chapel Down, Currys, Assura

Profit upgrade at Currys, Chapel Down shows resilience despite weak consumer market, Primary Health revises Assura offer

21 days ago - The Armchair Trader